|

GBP/USD to find support ahead of 1.35 – Westpac

BoE's Super Thursday is eyed. The Bank of England may affirm forward guidance and potential of further support, but downplay NIRP as vaccine rollouts lift prospects for the second half of 2021. Meanwhile, daily covid cases remain uncomfortably high but the lockdown is proving effective. 

The GBP/USD pair has dipped under 1.36 and is set to stay in a tight 1.3500-1.3750 range, economists at Westpac report.

Key quotes

“BoE’s policy announcement, minutes and latest Monetary Policy (MPR) report on February 4 will be key in assessing how the UK is faring after the EU trade deal and through the current Covid lockdown. They should also provide a clearer impression of how BoE views the economy and whether NIRP remains possible given the tepid comments towards it from Chief Economist Haldane, Dep Gov Broadbent and even Gov. Bailey last month. 

“The shocking spikes in covid cases into 2021 are now abating but remain uncomfortably high (latest daily case count being over 19k). Hospitalisation and mortality rates appear to have plateaued and the rollout of vaccines has already exceeded 10 M doses. Containing the pandemic will be critical in determining whether restrictions can be eased in March.” 

“GBP/USD is likely to remain in a tight 1.3500-1.3750 range until it is clear that the pandemic is contained.”

Author

More from FXStreet Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.